Strides Pharma Science Limited (STAR.NS)
INR 701.9
(1.52%)
INR 701.9
(1.52%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.24 Billion | 444.11 Million | -2.57 Billion | 4.81 Billion | 2.04 Billion | 600.55 Million |
| Net Income | -1.24 Billion | -2.67 Billion | -6.52 Billion | 2.89 Billion | 485.08 Million | 3.44 Billion |
| Depreciation & Amortization | 2.2 Billion | 2.43 Billion | 2.33 Billion | 2.06 Billion | 1.87 Billion | 1.71 Billion |
| Deferred income taxes | - | - | - | 1.35 Billion | 1.52 Billion | 364.99 Million |
| Stock-based compensation | 15.86 Million | 13.01 Million | -7.09 Million | 68.02 Million | 17.53 Million | 8.97 Million |
| Change in working capital | -787.32 Million | -4.57 Billion | -1.89 Billion | -3.28 Billion | -3.26 Billion | -3.23 Billion |
| Other non-cash items | 9.27 Billion | 5.25 Billion | 3.52 Billion | 1.71 Billion | 1.4 Billion | -1.7 Billion |
| Investing Cash Flow | -1.65 Billion | 3.02 Billion | -1.18 Billion | -5.2 Billion | 13.06 Billion | -1.48 Billion |
| Investments in PPE | -1.18 Billion | -949.38 Million | -1.43 Billion | -2.97 Billion | -1.5 Billion | -3.29 Billion |
| Acquisitions | 895.97 Million | 5.19 Billion | -2.19 Billion | -78.86 Million | -272.26 Million | -700.56 Million |
| Investment purchases | -783.98 Million | -1.57 Billion | -591.67 Million | -2.77 Billion | -1.1 Billion | -3.07 Billion |
| Sales/Maturities of investments | 18.02 Million | 191.48 Million | 2.16 Billion | 324.74 Million | 2.66 Billion | 1.58 Billion |
| Other Investing Activities | -603.71 Million | 160 Million | 872.41 Million | 294.21 Million | 13.27 Billion | 3.99 Billion |
| Financing Cash Flow | -4.01 Billion | -2.13 Billion | 4.21 Billion | -157.96 Million | -17.09 Billion | 1.94 Billion |
| Debt repayment | -3.84 Billion | -2.55 Billion | -2.68 Billion | -3.92 Billion | -13.74 Billion | -302.35 Million |
| Dividends payments | -135.17 Million | - | -224.31 Million | -179.15 Million | -1.53 Billion | -179.46 Million |
| Common Stock Repurchased | - | - | - | 3.9 Billion | -1.82 Billion | 2.37 Billion |
| Common Stock Issuance | 526.74 Million | 384.67 Million | 36.18 Million | 34.99 Million | 4.8 Million | 14 Million |
| Other Financing Activities | 29.31 Million | 26.29 Million | 7.08 Billion | 1.67 Million | 620 Thousand | 32.65 Million |
| Accounts receivables | 390.9 Million | -3.47 Billion | -587.95 Million | -1.24 Billion | -1.59 Billion | -1.72 Billion |
| Accounts payables | -1.48 Billion | -1.02 Billion | -1.59 Billion | 2.1 Billion | -45.99 Million | 1.54 Billion |
| Inventory | 307.04 Million | -81.38 Million | 281.86 Million | -4.14 Billion | -1.62 Billion | -3.05 Billion |
| Other working capital | -1.48 Billion | - | - | 1.00 | - | - |
| Cash at beginning of period | 3.09 Billion | 1.7 Billion | 1.25 Billion | 1.82 Billion | 3.65 Billion | 2.56 Billion |
| Cash at end of period | 1.91 Billion | 3.03 Billion | 1.7 Billion | 1.25 Billion | 1.82 Billion | 3.65 Billion |
| Capital Expenditure | -1.18 Billion | -949.38 Million | -1.43 Billion | -2.97 Billion | -1.5 Billion | -3.29 Billion |
| Effect of forex changes on cash | 1.62 Million | 1.46 Million | 1.28 Million | -12.2 Million | 148.48 Million | 38.98 Million |
| Net cash flow / Change in cash | -1.18 Billion | 1.32 Billion | 448.96 Million | -564 Million | -1.83 Billion | 1.09 Billion |
| Free Cash Flow | 3.05 Billion | -505.27 Million | -4.01 Billion | 1.83 Billion | 547.85 Million | -2.69 Billion |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 702.02 Million | 181.75 Million | -1.24 Billion | 496.67 Million | -1.31 Billion | -71.13 Million |
| Depreciation & Amortization | - | - | 2.2 Billion | 512.28 Million | 601.05 Million | 595.9 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 15.86 Million | 15.86 Million | - | - | - |
| Change in working capital | - | - | -787.32 Million | - | - | - |
| Other non-cash items | -702.02 Million | -181.75 Million | 9.27 Billion | -496.67 Million | 1.31 Billion | 71.13 Million |
| Investing Cash Flow | - | - | -1.65 Billion | - | - | - |
| Investments in PPE | - | - | -1.18 Billion | - | - | - |
| Acquisitions | - | - | 895.97 Million | - | - | - |
| Investment purchases | - | - | -783.98 Million | - | - | - |
| Sales/Maturities of investments | - | - | 18.02 Million | - | - | - |
| Other Investing Activities | - | - | -603.71 Million | - | - | - |
| Financing Cash Flow | - | - | -4.01 Billion | - | - | - |
| Debt repayment | - | - | -3.84 Billion | - | - | - |
| Dividends payments | - | - | -135.17 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 526.74 Million | - | - | - |
| Other Financing Activities | - | - | 29.31 Million | - | - | - |
| Accounts receivables | - | - | 390.9 Million | - | - | - |
| Accounts payables | - | - | -1.48 Billion | - | - | - |
| Inventory | - | - | 307.04 Million | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | - | 3.09 Billion | 2.63 Billion | 1.42 Billion | 3.09 Billion |
| Cash at end of period | - | - | 1.91 Billion | 3.65 Billion | 2.63 Billion | 4.28 Billion |
| Capital Expenditure | - | - | -1.18 Billion | - | - | - |
| Effect of forex changes on cash | - | - | 1.62 Million | - | - | - |
| Net cash flow / Change in cash | - | - | -1.18 Billion | 1.02 Billion | 1.2 Billion | 1.19 Billion |
| Free Cash Flow | - | - | 3.05 Billion | 1.02 Billion | 1.2 Billion | 1.19 Billion |
2459
6456
TVK
ASBFY
PEB
STMGF